Mergers and Acquisitions

Novartis to acquire Alcon

Novartis to acquire Alcon

By Nick Taylor

Novartis intends to acquire the remaining 75 per cent of Alcon for $39.3bn (€27.3bn), adding to the shares it bought in April 2008 and giving the big pharma control of the ophthalmic specialist.